I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 8 studies | 36% ± 24% | |
| natural killer cell | 7 studies | 18% ± 2% | |
| GABAergic neuron | 7 studies | 35% ± 20% | |
| endothelial cell | 6 studies | 25% ± 6% | |
| epithelial cell | 6 studies | 30% ± 10% | |
| CD16-negative, CD56-bright natural killer cell, human | 5 studies | 21% ± 4% | |
| astrocyte | 5 studies | 21% ± 5% | |
| oligodendrocyte | 5 studies | 24% ± 6% | |
| neuron | 4 studies | 24% ± 6% | |
| oligodendrocyte precursor cell | 4 studies | 24% ± 7% | |
| interneuron | 4 studies | 36% ± 19% | |
| plasmacytoid dendritic cell | 4 studies | 22% ± 6% | |
| CD16-positive, CD56-dim natural killer cell, human | 3 studies | 17% ± 1% | |
| hematopoietic precursor cell | 3 studies | 20% ± 1% | |
| ciliated cell | 3 studies | 30% ± 7% | |
| basal cell | 3 studies | 25% ± 5% | |
| transit amplifying cell | 3 studies | 24% ± 11% | |
| goblet cell | 3 studies | 19% ± 3% |
